loading
前日終値:
$0.85
開ける:
$0.8466
24時間の取引高:
28,486
Relative Volume:
0.07
時価総額:
$5.03M
収益:
-
当期純損益:
$-15.52M
株価収益率:
-0.0457
EPS:
-18.58
ネットキャッシュフロー:
$-16.61M
1週間 パフォーマンス:
-5.65%
1か月 パフォーマンス:
-32.13%
6か月 パフォーマンス:
-66.92%
1年 パフォーマンス:
-92.96%
1日の値動き範囲:
Value
$0.831
$0.8632
1週間の範囲:
Value
$0.8301
$0.95
52週間の値動き範囲:
Value
$0.702
$20.16

Revelation Biosciences Inc Stock (REVB) Company Profile

Name
名前
Revelation Biosciences Inc
Name
セクター
Healthcare (1137)
Name
電話
650-800-3717
Name
住所
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Name
職員
9
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
REVB's Discussions on Twitter

REVB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
REVB
Revelation Biosciences Inc
0.8483 5.04M 0 -15.52M -16.61M -18.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.44 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.32 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
438.75 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
924.10 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
199.49 42.58B 447.02M -1.18B -906.14M -6.1812

Revelation Biosciences Inc (REVB) 最新ニュース

pulisher
07:08 AM

Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com

07:08 AM
pulisher
03:36 AM

How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com

03:36 AM
pulisher
Nov 20, 2025

Revelation Says On Track for FDA Meeting Later This Year - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences on track for end-of-phase 1 meeting later this year - TipRanks

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com South Africa

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - Weatherford Democrat

Nov 20, 2025
pulisher
Nov 20, 2025

Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Analyzing recovery setups for Revelation Biosciences Inc. Equity Warrant investorsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

What catalysts could drive Revelation Biosciences Inc. Equity Warrant stock higher2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Can Revelation Biosciences Inc. stock continue upward trendPortfolio Profit Report & Long Hold Capital Preservation Tips - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Best data tools to analyze Revelation Biosciences Inc. Equity Warrant stockWeekly Loss Report & Weekly Breakout Stock Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Why Revelation Biosciences Inc. stock could outperform in 2025 - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Published on: 2025-11-16 12:31:36 - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Revelation Biosciences Inc. stock retracement – recovery analysisIPO Watch & Real-Time Chart Pattern Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Analyzing Revelation Biosciences Inc. with multi timeframe charts2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com

Nov 16, 2025
pulisher
Nov 13, 2025

Volume spikes in Revelation Biosciences Inc. stock – what they mean2025 Valuation Update & Daily Chart Pattern Signals - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - El Paso Times

Nov 12, 2025
pulisher
Nov 11, 2025

Will Revelation Biosciences Inc. Equity Warrant stock outperform Dow Jones indexWeekly Profit Report & Fast Gain Stock Tips - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Using data filters to optimize entry into Revelation Biosciences Inc.Rate Cut & Risk Adjusted Buy/Sell Alerts - newser.com

Nov 10, 2025

Revelation Biosciences Inc (REVB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$38.92
price up icon 1.75%
$30.58
price up icon 1.89%
$102.01
price up icon 0.33%
$97.38
price up icon 0.71%
biotechnology ONC
$346.01
price down icon 0.74%
$199.34
price down icon 0.32%
大文字化:     |  ボリューム (24 時間):